Semaglutide Before and After: What I See in Real Patients When patients ask me what results to expect, I emphasize that individual responses vary
While some of this research was funded by Novo Nordisk (the maker of Ozempic, Wegovy, Saxenda, and Victoza), the results are clearpeople on semaglutide lost nearly twice as much weight and hit the 5-percent weight-loss milestone in half the time
Key secondary endpoints included non-inferiority of tirzepatide (5 mg) compared to insulin degludec in HbA1c reduction, superiority of all tirzepatide doses over insulin degludec in HbA1c reduction and weight loss, and the proportion of participants achieving an HbA1c level below 7.0% at week 52
Pharmacokinetic data indicate that fasting plasma glucose (FPG) levels begin to decrease within two weeks, and steady-state plasma concentrations are typically achieved after six weeks of weekly dosing [59]
Patients should seek medical advice if they experience symptoms such as severe upper abdominal pain, often after meals